FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jessie L-S Au

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Urinary Bladder Neoplasms

Living Beings

Procedures

Concepts & Ideas

Biological Availability

Physiology

Cell Divisions

Co-author Network

Publications

TOP 3
Vishnu C Ramani; Jessie L-S Au; Anurag Purushothaman; Mark D Stewart; Camilla A Thompson; Israel Vlodavsky; Ralph D Sanderson
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.
Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jiabi Zhu; Yue Gao; Jessie L-S Au
Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jessie L-S Au (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vishnu C Ramani; Jessie L-S Au; Anurag Purushothaman; Mark D Stewart; Camilla A Thompson; Israel Vlodavsky; Ralph D Sanderson
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
The FEBS journal 2013;280(10):2294-306.
2012: Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.
Advanced drug delivery reviews 2012;64(1):29-39.
2011: Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jiabi Zhu; Yue Gao; Jessie L-S Au
Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability.
The AAPS journal 2011;13(4):585-97.
2011: Jie Wang; M Guillaume Wientjes; Yue Gao; Ze Lu; Jessie L-S Au
Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.
Nanomedicine (London, England) 2011;6(9):1605-20.
2011: Ho Lun Wong; Zancong Shen; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures.
Molecular pharmaceutics 2011;8(3):833-40.
2011: Ze Lu; Teng-Kuang Yeh; Jie Wang; Ling Chen; Greg Lyness; Yan Xin; M Guillaume Wientjes; Valerie Bergdall; Guillermo Couto; Francisco Alvarez-Berger; Carrie E Kosarek; Jessie L-S Au
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.
The Journal of urology 2011;185(4):1478-83.
2010: Leijun Hu; M Guillaume Wientjes; Jing Li; Jessie L-S Au
Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogs.
The AAPS journal 2010;12(4):586-91.
2010: Jie Wang; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Delivery of siRNA therapeutics: barriers and carriers.
The AAPS journal 2010;12(4):492-503.
2010: Jessie L-S Au; M Guillaume Wientjes
Combination intravesical hyperthermia and chemotherapy for bladder cancer.
Oncology (Williston Park, N.Y.) 2010;24(12):1155, 1160.
2010: Elaine T Lam; Jessie L-S Au; Gregory A Otterson; M Guillaume Wientjes; Ling Chen; Tong Shen; Yong Wei; Xiaobai Li; Tanios Bekaii-Saab; Anthony J Murgo; Rhonda R Jensen; Michael R Grever; Miguel A Villalona-Calero
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2010;66(6):1019-29.
2010: Ze Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Intraperitoneal therapy for peritoneal cancer.
Future oncology (London, England) 2010;6(10):1625-41.
2010: Jing Li; M Guillaume Wientjes; Jessie L-S Au
Pancreatic cancer: pathobiology, treatment options, and drug delivery.
The AAPS journal 2010;12(2):223-32.
2010: Liang Zhao; Jessie L-S Au; M Guillaume Wientjes
Comparison of methods for evaluating drug-drug interaction.
Frontiers in bioscience (Elite edition) 2010;2():241-9.
2009: Guohong Hu; Robert A Chong; Qifeng Yang; Yong Wei; Mario A Blanco; Feng Li; Michael Reiss; Jessie L-S Au; Bruce G Haffty; Yibin Kang
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Cancer cell 2009;15(1):9-20.
2008: Ze Lu; Max Tsai; Dan Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.
The Journal of pharmacology and experimental therapeutics 2008;327(3):673-82.
2008: Seth P Lerner; Jessie L-S Au
Risk-adapted use of intravesical chemotherapy.
BJU international 2008;102(9 Pt B):1247-53.
2008: Miguel A Villalona-Calero; Gregory A Otterson; M Guillaume Wientjes; F Weber; Tanios Bekaii-Saab; Donn Young; Anthony J Murgo; Rhonda Jensen; Teng-Kuang Yeh; Y Wei; Y Zhang; Charis Eng; Michael R Grever; Jessie L-S Au
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(11):1903-9.
2008: Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Intravesical treatments of bladder cancer: review.
Pharmaceutical research 2008;25(7):1500-10.
2008: Colin T Walsh; Yong Wei; M Guillaume Wientjes; Jessie L-S Au
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance.
Journal of translational medicine 2008;6():4.
2007: Max Tsai; Ze Lu; Jie Wang; Teng-Kuang Yeh; M Guillaume Wientjes; Jessie L-S Au
Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.
Pharmaceutical research 2007;24(9):1691-701.
2007: Dan Lu; M Guillaume Wientjes; Ze Lu; Jessie L-S Au
Tumor priming enhances delivery and efficacy of nanomedicines.
The Journal of pharmacology and experimental therapeutics 2007;322(1):80-8.
2007: Leijun Hu; Jessie L-S Au; M Guillaume Wientjes
Computational modeling to predict effect of treatment schedule on drug delivery to prostate in humans.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1278-87.
2007: Ronnie Ortiz; Jessie L-S Au; Ze Lu; Yuebo Gan; M Guillaume Wientjes
Biodegradable intraprostatic doxorubicin implants.
The AAPS journal 2007;9(2):E241-50.
2006: Jie Wang; Ze Lu; Jessie L-S Au
Protection against chemotherapy-induced alopecia.
Pharmaceutical research 2006;23(11):2505-14.
2006: Carrie E Kosarek; Xiao Hu; C Guillermo Couto; William C Kisseberth; Eric M Green; Jessie L-S Au; M Guillaume Wientjes
Phase I evaluation of low-dose suramin as chemosensitizer of doxorubicin in dogs with naturally occurring cancers.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2006;20(5):1172-7.
2006: Yuebo Gan; M Guillaume Wientjes; Jessie L-S Au
Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors.
Pharmaceutical research 2006;23(6):1324-31.
2006: Danny Chen; Sae Heum Song; M Guillaume Wientjes; Teng-Kuang Yeh; Liang Zhao; Miguel A Villalona-Calero; Gregory A Otterson; Rhonda Jensen; Michael R Grever; Anthony J Murgo; Jessie L-S Au
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.
Pharmaceutical research 2006;23(6):1265-74.
2005: Ze Lu; Trini S-S Wientjes; Jessie L-S Au
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Pharmaceutical research 2005;22(7):1069-78.
2005: Yan Xin; Greg Lyness; Danny Chen; SaeHeum Song; M Guillaume Wientjes; Jessie L-S Au
Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
The Journal of urology 2005;174(1):322-7.
2005: Teng-Kuang Yeh; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Formulating paclitaxel in nanoparticles alters its disposition.
Pharmaceutical research 2005;22(6):867-74.
2005: M Guillaume Wientjes; Jenny H Zheng; Leijun Hu; Yuebo Gan; Jessie L-S Au
Intraprostatic chemotherapy: distribution and transport mechanisms.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4204-11.
2004: Liang Zhao; M Guillaume Wientjes; Jessie L-S Au
Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7994-8004.
2004: Ze Lu; Teng-Kuang Yeh; Max Tsai; Jessie L-S Au; M Guillaume Wientjes
Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7677-84.
2004: Adam Ogden; M Guillaume Wientjes; Jessie L-S Au
Suramin as a chemosensitizer: oral pharmacokinetics in rats.
Pharmaceutical research 2004;21(11):2058-63.
2004: SaeHeum Song; Bei Yu; Yong Wei; M Guillaume Wientjes; Jessie L-S Au
Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6058-65.
2003: Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L-S Au
Drug delivery and transport to solid tumors.
Pharmaceutical research 2003;20(9):1337-50.
2003: Miguel A Villalona-Calero; M Guillaume Wientjes; Gregory A Otterson; Steven Kanter; Donn Young; Anthony J Murgo; Beth Fischer; Carrie DeHoff; Danny Chen; Teng-Kuang Yeh; SaeHeum Song; Michael R Grever; Jessie L-S Au
Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3303-11.
2003: Jeffrey S Johnston; Andrew Johnson; Yuebo Gan; M Guillaume Wientjes; Jessie L-S Au
Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.
Pharmaceutical research 2003;20(7):957-61.
2003: Yiqun Mo; Yuebo Gan; SaeHeum Song; Jeffrey Johnston; Xiaodong Xiao; M Guillaume Wientjes; Jessie L-S Au
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Cancer research 2003;63(3):579-85.
2003: Seong Hoon Jang; M Guillaume Wientjes; Jessie L-S Au
Interdependent effect of P-glycoprotein-mediated drug efflux and intracellular drug binding on intracellular paclitaxel pharmacokinetics: application of computational modeling.
The Journal of pharmacology and experimental therapeutics 2003;304(2):773-80.
2003: Dong Li; Seong H Jang; Jonghan Kim; M Guillaume Wientjes; Jessie L-S Au
Enhanced drug-induced apoptosis associated with P-glycoprotein overexpression is specific to antimicrotubule agents.
Pharmaceutical research 2003;20(1):45-50.
2003: Danny Chen; Di Song; M Guillaume Wientjes; Jessie L-S Au
Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):363-9.
2002: Yuebo Gan; Yiqun Mo; Jeffrey Johnston; Jie Lu; M Guillaume Wientjes; Jessie L-S Au
Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase.
FEBS letters 2002;527(1-3):10-4.
2002: Jessie L-S Au; Seong H Jang; M Guillaume Wientjes
Clinical aspects of drug delivery to tumors.
Journal of controlled release : official journal of the Controlled Release Society 2002;78(1-3):81-95.
2001: Yuebo Gan; K J Engelke; C A Brown; Jessie L-S Au
Telomere amount and length assay.
Pharmaceutical research 2001;18(12):1655-9.
2001: D Li; Yuebo Gan; M Guillaume Wientjes; RA Badalament; Jessie L-S Au
Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors.
The Journal of urology 2001;166(6):2500-5.
2001: Y Zhang; SaeHeum Song; F Yang; Jessie L-S Au; M Guillaume Wientjes
Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
The Journal of pharmacology and experimental therapeutics 2001;299(2):426-33.
2001: Seong Hoon Jang; M Guillaume Wientjes; Jessie L-S Au
Kinetics of P-glycoprotein-mediated efflux of paclitaxel.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1236-42.
2001: SaeHeum Song; M Guillaume Wientjes; C Walsh; Jessie L-S Au
Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases.
Cancer research 2001;61(16):6145-50.
2001: Jessie L-S Au; Seong H Jang; J Zheng; C T Chen; S Song; L Hu; M Guillaume Wientjes
Determinants of drug delivery and transport to solid tumors.
Journal of controlled release : official journal of the Controlled Release Society 2001;74(1-3):31-46.
2001: Dong Li; Jessie L-S Au
Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.
Pharmaceutical research 2001;18(7):907-13.
2001: Yuebo Gan; Y Mo; J E Kalns; J Lu; K Danenberg; P Danenberg; M Guillaume Wientjes; Jessie L-S Au
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1313-9.
2001: Jessie L-S Au; RA Badalament; M Guillaume Wientjes; D C Young; J A Warner; P L Venema; D L Pollifrone; J D Harbrecht; J L Chin; S P Lerner; B J Miles
Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.
Journal of the National Cancer Institute 2001;93(8):597-604.
2001: Yuebo Gan; J Lu; A Johnson; M Guillaume Wientjes; D E Schuller; Jessie L-S Au
A quantitative assay of telomerase activity.
Pharmaceutical research 2001;18(4):488-93.
2001: Seong Hoon Jang; M Guillaume Wientjes; Jessie L-S Au
Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.
The Journal of pharmacology and experimental therapeutics 2001;296(3):1035-42.
2000: SaeHeum Song; M Guillaume Wientjes; Yuebo Gan; Jessie L-S Au
Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8658-63.
2000: HJ Kuh; Seong Hoon Jang; M Guillaume Wientjes; Jessie L-S Au
Computational model of intracellular pharmacokinetics of paclitaxel.
The Journal of pharmacology and experimental therapeutics 2000;293(3):761-70.
2000: NJ Millenbaugh; M Guillaume Wientjes; Jessie L-S Au
A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.
Cancer chemotherapy and pharmacology 2000;45(4):265-72.
1999: HJ Kuh; Seong Hoon Jang; M Guillaume Wientjes; JR Weaver; Jessie L-S Au
Determinants of paclitaxel penetration and accumulation in human solid tumor.
The Journal of pharmacology and experimental therapeutics 1999;290(2):871-80.
1999: I Knemeyer; M Guillaume Wientjes; Jessie L-S Au
Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
Cancer chemotherapy and pharmacology 1999;44(3):241-8.
1999: JR Weaver; M Guillaume Wientjes; Jessie L-S Au
Regional heterogeneity and pharmacodynamics in human solid tumor histoculture.
Cancer chemotherapy and pharmacology 1999;44(4):335-42.
1999: NJ Millenbaugh; M Guillaume Wientjes; Jessie L-S Au
Accuracy and precision of pharmacodynamic exponent.
Pharmaceutical research 1999;16(1):170-3.
1998: Yuebo Gan; M Guillaume Wientjes; Jessie L-S Au
Relationship between paclitaxel activity and pathobiology of human solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):2949-55.
1998: Yuebo Gan; Jessie L-S Au; J Lu; M Guillaume Wientjes
Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures.
Pharmaceutical research 1998;15(11):1760-6.
1998: JR Weaver; Yuebo Gan; Jessie L-S Au
Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.
Pharmaceutical research 1998;15(10):1546-51.
1998: C T Chen; Yuebo Gan; Jessie L-S Au; M Guillaume Wientjes
Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation.
Cancer research 1998;58(13):2777-83.
1998: Jessie L-S Au; D Li; Yuebo Gan; X Gao; A L Johnson; Jeffrey Johnston; NJ Millenbaugh; Seong Hoon Jang; HJ Kuh; C T Chen; M Guillaume Wientjes
Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
Cancer research 1998;58(10):2141-8.
1998: C T Chen; Jessie L-S Au; M Guillaume Wientjes
Pharmacodynamics of doxorubicin in human prostate tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):277-82.
1998: Yuebo Gan; M Guillaume Wientjes; J Lu; Jessie L-S Au
Cytostatic and apoptotic effects of paclitaxel in human breast tumors.
Cancer chemotherapy and pharmacology 1998;42(3):177-82.
1998: X Gao; Jessie L-S Au; RA Badalament; M Guillaume Wientjes
Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):139-43.
1998: NJ Millenbaugh; Yuebo Gan; Jessie L-S Au
Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors.
Pharmaceutical research 1998;15(1):122-7.
1997: Jessie L-S Au; N Panchal; Dong Li; Yuebo Gan
Apoptosis: a new pharmacodynamic endpoint.
Pharmaceutical research 1997;14(12):1659-71.
1997: JR Weaver; Jessie L-S Au
Application of automatic thresholding in image analysis scoring of cells in human solid tumors labeled for proliferation markers.
Cytometry 1997;29(2):128-35.
1997: Di Song; M Guillaume Wientjes; Yuebo Gan; Jessie L-S Au
Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):901-9.
1997: H J Kang; M Guillaume Wientjes; Jessie L-S Au
Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.
Pharmaceutical research 1997;14(3):337-44.
1997: W C Yen; Jessie L-S Au
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
Pharmaceutical research 1997;14(2):241-5.
1997: JR Weaver; Jessie L-S Au
Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers.
Cytometry 1997;27(2):189-99.
1997: Jessie L-S Au; J Kalns; Yuebo Gan; M Guillaume Wientjes
Pharmacologic effects of paclitaxel in human bladder tumors.
Cancer chemotherapy and pharmacology 1997;41(1):69-74.
1997: Di Song; M Guillaume Wientjes; Jessie L-S Au
Bladder tissue pharmacokinetics of intravesical taxol.
Cancer chemotherapy and pharmacology 1997;40(4):285-92.
1996: W C Yen; T Schmittgen; Jessie L-S Au
Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
Pharmaceutical research 1996;13(12):1887-91.
1996: W C Yen; M Guillaume Wientjes; Jessie L-S Au
Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.
Pharmaceutical research 1996;13(9):1305-12.
1996: Yuebo Gan; M Guillaume Wientjes; R A Badalament; Jessie L-S Au
Pharmacodynamics of doxorubicin in human bladder tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1275-83.
1996: Yuebo Gan; M Guillaume Wientjes; D E Schuller; Jessie L-S Au
Pharmacodynamics of taxol in human head and neck tumors.
Cancer research 1996;56(9):2086-93.
1996: T K Yeh; H J Kang; M Guillaume Wientjes; Jessie L-S Au
Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats.
Pharmaceutical research 1996;13(4):628-32.
1996: D Song; L F Hsu; Jessie L-S Au
Binding of taxol to plastic and glass containers and protein under in vitro conditions.
Journal of pharmaceutical sciences 1996;85(1):29-31.
1996: M Guillaume Wientjes; R A Badalament; Jessie L-S Au
Penetration of intravesical doxorubicin in human bladders.
Cancer chemotherapy and pharmacology 1996;37(6):539-46.
1995: X Gao; M Guillaume Wientjes; Jessie L-S Au
Use of drug kinetics in dermis to predict in vivo blood concentration after topical application.
Pharmaceutical research 1995;12(12):2012-7.
1995: X Gao; M Guillaume Wientjes; Jessie L-S Au
Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.
Pharmaceutical research 1995;12(12):1901-6.
1995: J E Kalns; NJ Millenbaugh; M Guillaume Wientjes; Jessie L-S Au
Design and analysis of in vitro antitumor pharmacodynamic studies.
Cancer research 1995;55(22):5315-22.
1995: M Guillaume Wientjes; T G Pretlow; R A Badalament; J K Burgers; Jessie L-S Au
Histocultures of human prostate tissues for pharmacologic evaluation.
The Journal of urology 1995;153(4):1299-302.
1995: E Gupta; M Guillaume Wientjes; Jessie L-S Au
Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.
Pharmaceutical research 1995;12(1):108-12.
1994: H J Kang; M Guillaume Wientjes; Jessie L-S Au
Tissue pharmacokinetics of 2',3'-dideoxyinosine in rats.
Biochemical pharmacology 1994;48(11):2109-16.
1994: X Gao; Buffington Tony; Jessie L-S Au
Effect of interstitial cystitis on drug absorption from urinary bladder.
The Journal of pharmacology and experimental therapeutics 1994;271(2):818-23.
1994: T D Schmittgen; J M Weaver; R A Badalament; M Guillaume Wientjes; E A Klein; Donn C Young; Jessie L-S Au
Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology.
The Journal of urology 1994;152(5 Pt 1):1632-6.
1994: M Chai; M Guillaume Wientjes; R A Badalament; J K Burgers; Jessie L-S Au
Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients.
The Journal of urology 1994;152(2 Pt 1):374-8.
1994: E Mukherji; Jessie L-S Au; Lawrence E Mathes
Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.
Antimicrobial agents and chemotherapy 1994;38(7):1573-9.
1994: E Mukherji; NJ Millenbaugh; Jessie L-S Au
Percutaneous absorption of 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1994;11(6):809-15.
1993: T K Yeh; James T Dalton; Jessie L-S Au
High-performance liquid chromatographic determination of pentamidine in plasma.
Journal of chromatography 1993;622(2):255-61.
1993: Jessie L-S Au; M Guillaume Wientjes; Thomas J Rosol; A Koolemans-Beynen; E A Goebel; D E Schuller
Histocultures of patient head and neck tumors for pharmacodynamics studies.
Pharmaceutical research 1993;10(10):1493-9.
1993: M Guillaume Wientjes; R A Badalament; R C Wang; F Hassan; Jessie L-S Au
Penetration of mitomycin C in human bladder.
Cancer research 1993;53(14):3314-20.
1993: S L Bramer; Jessie L-S Au; M Guillaume Wientjes
Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
The Journal of pharmacology and experimental therapeutics 1993;265(2):731-8.
1993: S L Bramer; M Guillaume Wientjes; Jessie L-S Au
Absorption of 2',3'-dideoxyinosine from lower gastrointestinal tract in rats and kinetic evidence of different absorption rates in colon and rectum.
Pharmaceutical research 1993;10(5):763-70.
1993: James T Dalton; Jessie L-S Au
2',3'-Dideoxyinosine is not metabolized in human placenta.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(3):544-6.
1993: M Guillaume Wientjes; R A Badalament; Jessie L-S Au
Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.
Cancer chemotherapy and pharmacology 1993;32(4):255-62.
1992: M Guillaume Wientjes; E Mukherji; Jessie L-S Au
Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1992;9(8):1070-5.
1992: M Guillaume Wientjes; Jessie L-S Au
Pharmacokinetics of oral 2',3'-dideoxyinosine in rats.
Pharmaceutical research 1992;9(6):822-5.
1992: James T Dalton; M D Harrington; Jessie L-S Au
Evidence of significant absorption of antipyrine from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1992;260(2):608-13.
1992: T D Schmittgen; A Koolemans-Beynen; T E Webb; Thomas J Rosol; Jessie L-S Au
Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.
Cancer chemotherapy and pharmacology 1992;30(1):25-30.
1991: James T Dalton; M Guillaume Wientjes; R A Badalament; J R Drago; Jessie L-S Au
Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Cancer research 1991;51(19):5144-52.
1991: M Guillaume Wientjes; James T Dalton; R A Badalament; J R Drago; Jessie L-S Au
Bladder wall penetration of intravesical mitomycin C in dogs.
Cancer research 1991;51(16):4347-54.
1991: T D Schmittgen; M Guillaume Wientjes; R A Badalament; Jessie L-S Au
Pharmacodynamics of mitomycin C in cultured human bladder tumors.
Cancer research 1991;51(15):3849-56.
1991: Jessie L-S Au; James T Dalton; M Guillaume Wientjes
Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
The Journal of pharmacology and experimental therapeutics 1991;258(1):357-64.
1991: M Guillaume Wientjes; Jessie L-S Au
High-performance liquid chromatographic analysis of 2',3'-dideoxyinosine in biological samples.
Journal of chromatography 1991;563(2):400-6.
1991: M Guillaume Wientjes; James T Dalton; R A Badalament; B M Dasani; J R Drago; Jessie L-S Au
A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.
Pharmaceutical research 1991;8(2):168-73.
1991: T D Schmittgen; Jessie L-S Au; M Guillaume Wientjes; R A Badalament; J R Drago
Cultured human bladder tumors for pharmacodynamic studies.
The Journal of urology 1991;145(1):203-7.
1989: James T Dalton; E R Geuns; Jessie L-S Au
High-performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine.
Journal of chromatography 1989;495():330-7.
1989: Jessie L-S Au; L C Gunnarsson
Absorption of 5'-deoxy-5-fluorouridine from colon.
Pharmaceutical research 1989;6(4):323-7.
1989: S L Bramer; L C Gunnarsson; Jessie L-S Au
Biologic activity of 5'-deoxy-5-fluorouridine by rectal administration.
Pharmaceutical research 1989;6(4):318-22.
1989: Jessie L-S Au; M H Su; M Guillaume Wientjes
Extraction of intracellular nucleosides and nucleotides with acetonitrile.
Clinical chemistry 1989;35(1):48-51.
1988: Jessie L-S Au; M Guillaume Wientjes; S L Bramer
Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.
Cancer chemotherapy and pharmacology 1988;22(1):5-10.
1987: Jessie L-S Au; M H Su; M Guillaume Wientjes
Isocratic ion-pair reversed-phase high-performance liquid chromatographic analysis of ATP and ADP.
Journal of chromatography 1987;423():308-12.
1987: M Guillaume Wientjes; Jessie L-S Au
Inhibition of intestinal pyrimidine nucleoside phosphorylases.
Pharmaceutical research 1987;4(5):425-8.
1987: Jessie L-S Au
Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
Journal of pharmaceutical sciences 1987;76(9):699-702.
1987: Jessie L-S Au; Y M Rustum; H K Slocum
Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.
Cancer drug delivery 1987;4(3):137-44.